Results 211 to 220 of about 379,515 (350)

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Darolutamide plus androgen‐deprivation therapy (ADT) improved metastasis‐free survival (MFS) by 2 years and reduced the risk of death by 31% in nonmetastatic castration‐resistant prostate cancer (nmCRPC) in ARAMIS. Prior local therapy may influence the efficacy of subsequent systemic therapy.
Matthias Saar, Karim Fizazi, Neal D. Shore, Matthew Smith, Jan‐Erik Damber, Andrey Semenov, Maria J. Ribal, Alison Birtle, Jérôme Rigaud, Christopher J. D. Wallis, Marc‐Oliver Grimm, Susan Halabi, Andrew J. Armstrong, Ateesha F. Mohamed, Patrick Adorjan, Shankar Srinivasan, Frank Verholen, Alicia K. Morgans, D. Robert Siemens   +18 more
wiley   +1 more source

Urologic Fistulas in Czech Women With Gynaecologic Malignancies. [PDF]

Cancer Rep (Hoboken)
Spacek J, Ndukwe MO, Ubom AEB, Sirak I, Hoffman P, Karasek D, Petera J, Brodak M, Balik M, Habes D, Pacovsky J.   +10 more
europepmc   +1 more source

Urincholesterinbestimmung im Rahmen der Früherkennung und Verlaufskontrolle von Harnblasentumoren [PDF]

, 1984
Bichler, K.-H., Jüngst, Dieter, Tauber, R.   +2 more
core   +1 more source

The Physiology of Lived Experience: And then there was one – the story of a radical nephrectomy

Experimental Physiology, EarlyView.
Michael J. Shattock
wiley   +1 more source

Network and Gene Set Enrichment Analysis of Adipokine Drivers of Prostate Cancer; Unravelling the Mechanistic Link Between Excess Adiposity and Prostate Cancer Risk

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Adiposity‐Based Chronic Disease (ABCD), a novel model housing obesity, insulin resistance, and adipokine‐related inflammation, increases the risk of aggressive prostate cancer (PCa), posttreatment PCa recurrence, and PCa mortality. This paper provides a new network analysis of relevant metabolic drivers to provide insight into the ...
Zachary Dovey, Elena Tomas Bort, Jeffrey I. Mechanick   +2 more
wiley   +1 more source

Risk of malignancy of cytologic categories and post‐biopsy clinical management of renal oncocytic neoplasms

Cancer Cytopathology, Volume 134, Issue 1, January 2026.
Abstract Background Renal mass biopsy (RMB) cytology is increasingly used for the pretreatment evaluation of renal masses. Cytopathologic classification of RMB specimens facilitates communication with clinicians and provides valuable risk stratification to guide management decisions. This study evaluated the risk of malignancy (ROM) associated with RMB
Xiaoqi Lin
wiley   +1 more source

Gross hematuria secondary to vesicular varices: an unusual long-term sequela of inferior vena cava ligation and resection case report. [PDF]

Urol Case Rep
Prokop DJ, Saini S, Vemana G.
europepmc   +1 more source

Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years [PDF]

, 2017
Dehner, Louis P, et al,
core   +1 more source

Multidimensional Assessment of Neurological Adverse Reactions Related to PD‐1 Inhibitors: A Real‐World Pharmacovigilance Study

CNS Neuroscience &Therapeutics, Volume 32, Issue 1, January 2026.
This pharmacovigilance study systematically analyzed PD‐1 inhibitor–associated neurological adverse events using FAERS data from 2014 to 2024. Central nervous system toxicities, including encephalitis and brainstem encephalitis, were most prominent. Older age, female sex, specific cancer types, and combination therapies increased the risk, with most ...
Xiaofeng Hu, Xiaoli Wang, Bufu Tang, Dehuan Zhang, Rongbing Cai, Hui Jiang, Yaling Lin, Yiheng Song, Yiou Wang, Hairuo Huang, Dandan Guo, Xubin Sun, Hongjie Fan   +12 more
wiley   +1 more source

The Use of Artificial Intelligence in Urologic Oncology: Current Insights and Challenges. [PDF]

Res Rep Urol
Cicchetti R, Amparore D, Tamborino F, Tătaru OS, Ferro M, Digiacomo A, Litterio G, Orsini A, Granata S, Campi R, Masieri L, Schips L, Marchioni M.   +12 more
europepmc   +1 more source